Genital Warts Removal, Brunei | HIV STD TESTING TREATMENT™

Genital Warts Removal, Brunei | HIV STD TESTING TREATMENT™ @beautybrunei_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Brunei - Private and confidential service. Definitions, references, and latest news.

Description

• Genital Warts
• Genital Warts Treatment / Genital Warts Removal

SHIM CLINIC 168 Bedok South Avenue 3 #01-473 Singapore 460168 Tel: (+65) 6100 7446 Fax: (+65) 6449 7446 24hr Answering Tel: (+65) 6333 5550 Web: Genital Warts Removal, Brunei

Opening Hours Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm Saturday & Sunday: 7 pm to 11 pm Public Holidays: Closed Last registration: half hour before closing time. Walk-in clinic. Appointments not required. Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.

References

• Genital warts - Wikipedia, the free encyclopedia
• Genital warts: Definition from Answers.com

Comparative evaluation of the Abbott HIV-1 RealTime™ assay with the Standard Roche COBAS(®) Amplicor™ HIV-1 Monitor(®) Test, v1.5 for determining HIV-1 RNA levels in plasma specimens from Pune, India.
Thu, 23 May 2013 16:50:03 +0100 | Journal of Virological Methods
Authors: Khopkar P, Mallav V, Chidrawar S, Kulkarni S

Metagenomic sequencing of "HPV-negative" condylomas detects novel putative HPV types.
Thu, 23 May 2013 13:25:06 +0100 | Virology
Metagenomic sequencing of "HPV-negative" condylomas detects novel putative HPV types.

Depletion of polycistronic transcripts using short interfering RNAs: cDNA synthesis method affects levels of non-targeted genes determined by quantitative PCR
Tue, 21 May 2013 04:00:00 +0100 | Virology Journal
Conclusions:

High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma
Mon, 20 May 2013 04:00:00 +0100 | Cancer
CONCLUSIONSThis novel measure of tumor genetic heterogeneity is significantly associated with tumor progression and adverse treatment outcomes, thereby supporting the hypothesis that higher genetic heterogeneity portends a worse clinical outcome in patients with HNSCC. The prognostic value of some known biomarkers may be the result of their association with high genetic heterogeneity. MATH provides a useful measure of that heterogeneity to be prospectively validated as NGS data from homogeneously treated patient cohorts become available Cancer 2013. © 2013 American Cancer Society. (Source: Cancer)

Study Explores Providers' Perceptions Of Parental Concerns About HPV Vaccination
Fri, 17 May 2013 07:00:00 +0100 | Health News from Medical News Today
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents are more likely to defer the vaccination. The findings appear online in the May issue of the Journal of Health Care for the Poor and Underserved. Cervical cancer incidence and mortality are markedly higher for low-income and minority women due to higher rates of HPV and limited access to screening and treatment... (Source: Health News from Medical News Today)

Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site
Fri, 17 May 2013 04:00:00 +0100 | Sexually Transmitted Infections
Conclusions

Detection of high risk human papillomavirus by hybrid capture II(r) according cytological findings in women treated for squamous intraepithelial lesions of the cervix, period 2006/2010
Thu, 16 May 2013 16:10:18 +0100 | Revista Brasileira de Epidemiologia
CONCLUSION: La detección de HR-HPV por CH II(r), así como los valores de carga viral relativa altos, en especial en mujeres con NSIL podrían ayudar a identificar mujeres tratadas con riesgo a desarrollar recidivas, contribuyendo así a fortalecer el programa de prevención de cáncer de cuello uterino. OBJECTIVE: To determinate the frequency of high risk human papillomavirus (HR-HPV) by hybrid capture II (r) (CH II(r)), according cytology results in women treated for squamous intraepithelial lesions of the cervix (SIL). MATERIAL AND METHODS: A descriptive cross-sectional study of a series of cases that included 122 women treated, 79 (75%) for low grade SIL (LSIL) and 43 (35%) for high grade SIL (HSIL) attending at the HPV Laboratory at the Heal...

Cross-roads in the classification of papillomaviruses.
Thu, 16 May 2013 04:00:00 +0100 | Virology
Authors: de Villiers EM

Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma [HEAD & NECK]
Wed, 15 May 2013 04:00:00 +0100 | American Journal of Neuroradiology
CONCLUSIONS:

New BUSM study explores providers' perceptions of parental concerns about HPV vaccination
Tue, 14 May 2013 04:00:00 +0100 | EurekAlert! - Social and Behavioral Science
(Boston University Medical Center) A new Boston University School of Medicine study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus, while white, middle-class parents are more likely to defer the vaccination. (Source: EurekAlert! - Social and Behavioral Science)